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Background: Reduced ventilation in lung regions affected by chronic obstructive pulmonary disease (COPD),
reflected as inhomogeneities in the single-photon emission computed tomography (SPECT) lung image, is
correlated to disease advancement. An analysis method for measuring these inhomogeneities is proposed in this
work. The first aim was to develop a quantitative analysis method that could discriminate between Monte Carlo
simulated normal and COPD lung SPECT images. A second aim was to evaluate the ability of the present method
to discriminate between human subjects with advanced COPD and healthy volunteers.
Methods: In the simulated COPD study, different activity distributions in the lungs were created to mimic the
healthy lung (normal) and different levels of COPD. Gamma camera projections were Monte Carlo simulated,
representing clinically acquired projections of a patient who had inhaled 125 MBq 99mTc-Technegas followed by a
10-min SPECT examination. Reconstructions were made with iterative ordered subset expectation maximisation. The
coefficient of variance (CV) was calculated for small overlapping volumes covering the 3D reconstructed activity
distribution. A CV threshold value (CVT) was calculated as the modal value of the CV distribution of the simulated
normal. The area under the distribution curve (AUC), for CV values greater than CVT, AUC(CVT), was then calculated.
Moreover, five patients with advanced emphysema and five healthy volunteers inhaled approximately 75 MBq
99mTc-Technegas immediately before the 20-min SPECT acquisition. In the human study, CVT was based on the
mean CV distribution of the five healthy volunteers.
Results: A significant difference (p < 0.001) was found between the Monte-Carlo simulated normal and COPD lung
SPECT examinations. The present method identified a total reduction of ventilation of approximately 5%, not visible
to the human eye in the reconstructed image. In humans the same method clearly discriminated between the five
healthy volunteers and five patients with advanced COPD (p < 0.05).
Conclusions: While our results are promising, the potential of the AUC(CVT) method to detect less advanced COPD
in patients needs further clinical studies.
Keywords: Quantitative lung SPECT; Ventilation; Iterative reconstruction; Lung disorder; Monte Carlo; COPDBackground
Chronic obstructive pulmonary disease (COPD) is cha-
racterised by obstructed airways and parenchymal destruc-
tion. Characteristically, varying degrees of abnormalities
are found in different parts of the COPD lung, and some
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in any medium, provided the original work is pabnormal ventilation distribution is the first abnormality
to be detected in the early stages of the disease [1].
COPD starts with inflammation and obstruction in
peripheral airways [2,3] where the resistance is very low
[4]. Therefore, conventional lung function tests (spiro-
metry) are insensitive [5]. Imaging techniques primarily
aim at localising lesions, but as these techniques become
digital, new interpretative possibilities are now arising. By
using high-resolution computed tomography (HRCT),
mild emphysema may be assessed by quantification of the
density distribution [6]. Although computed tomographyan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 A cross-section of the phantom visualising selected
tissues, respiratory motion and heartbeat. A coronal slice of the
phantom in units of linear attenuation coefficients, together with used
grey scale ranging from μ = 0 cm−1 as black to μ = 0.219 cm−1 as white.
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in the lung tissue, it provides little information about lung
function reduction [6]. In contrast, lung function reduc-
tion is both imaged and assessed directly by lung single-
photon emission computed tomography (lung SPECT), a
method often used in diagnosis of pulmonary embolism
[7,8]. Hence, previous reports have described ventilation
and perfusion SPECT as a sensitive method of detecting
early changes in COPD [9]. Moreover, SPECT findings
correlate significantly with emphysema scored by HRCT
and lung function tests [9].
It is common to interpret lung SPECT images qualita-
tively. However, quantitative information obtained from
a SPECT examination has the potential to provide much
more information. Different quantitative methods for
assessment of lung SPECT images have been reported
[10-16]. Xu et al. [11] quantified inhomogeneities in ven-
tilation SPECT images of COPD patients using 50 MBq
of Technegas (Vita Medical Limited, Sydney, Australia),
measuring the coefficient of variance (CV) in the lung
elements. In that study, transaxial SPECT slices (1-cm
thickness with 3.5-cm spacing) were acquired using a low-
energy, general-purpose collimator, filtered back-projection
with non-homogeneous attenuation correction and a 2D
Hann post-filter. These were then divided into 2 × 2 × 1
cm3 elements. By that method, it was possible to separate
non-smoking healthy subjects and ‘healthy smokers’ from
COPD patients. Importantly, however, that method was
not sensitive enough to discriminate between healthy
non-smokers and healthy smokers. Our overall aim is to
develop a quantitative method sensitive enough to discri-
minate between these two groups. Therefore, the present
study is currently followed by a larger clinical study eva-
luating the ability of the method used in this paper to
differentiate between healthy non-smokers and healthy
smokers.
The present study had two aims. Firstly, we wanted to
develop a quantitative method using Monte Carlo simu-
lated lung SPECT images of phantom lungs that could
discriminate between uniform (healthy, simulated normal)
and non-uniform (non-healthy, simulated COPD) activity
distributions corresponding to COPD lung changes of
varying severity. Secondly, we wished to evaluate the
ability of the same method in a clinical environment to
differentiate between human subjects with advanced
COPD and healthy volunteers.
Methods
Lung phantom and Monte Carlo simulations
The NCAT phantom [17] with a lung volume (air, blood
and parenchyma) of 4.2 litres was used. The lung
volume corresponded to a 65-year-old male (70 kg,
180 cm) in a supine position and in the middle of the re-
spiratory cycle [18,19]. The arms were held over thehead (see Figure 1). The respiratory motion and heart-
beat of the phantom were employed throughout the
study, i.e. the phantom was dynamic. The phantom
consisted of a 256 × 256 × 256 matrix with a voxel size
of 1.65 × 1.65 × 1.65 mm3. Muscle, fat, lung, spine bone,
rib bone, blood and heart tissues were selected. The
densities and elemental compositions of these tissues
were obtained from ICRP 89 [20] and the photon inter-
action cross sections from Berger et al. [21].
The simulated healthy distribution, in the following
called normal, was represented by a homogeneous activity
distribution in the phantom lung (the ‘uniform’ distribu-
tion). Simulated COPD lung changes of varying severity
were represented by eight different non-homogeneous
activity distributions. Small spherical lesions were chosen
to create inhomogeneous ventilation distributions. These
distributions are defined in Table 1. The activity concen-
trations in the lesions were 50%, 25% or 0% of the healthy
surrounding lung tissue. The reduced activity levels in the
lesions reflect the magnitude of the reduced ventilation.
No activity was located elsewhere in the body. The density
of the lesions was the same as for the lung. In Table 1,
coronal slices are shown including motion artefacts to
illustrate the distributions observed by the gamma camera
during projection acquisition.
SPECT projections from these activity distributions
were Monte Carlo simulated using the software SIMIND,
version 4.9d [21,22]. The projection data incorporated the
Table 1 Phantom activity distribution notations and their descriptions
Distribution
notation
Coronal slice Number Distribution description Total reduction
of ventilation (%)
Simulated normal Uniform 1 Homogeneous activity distribution 0
Simulated COPD 1 cm50% 10% evenly 2 Lesions with a diameter of 1 cm with 50%
activity concentration, evenly distributed
over the lung volume, occupying 10% of
the total lung volume.
5
1 cm50% 12% centred 3 Lesions with a diameter of 1 cm with 50%
activity concentration, centred to the large
bronchial tubes, occupying 12% of the total
lung volume.
6
1 cm0% 10% evenly 4 Lesions with a diameter of 1 cm with 0%
activity concentration, evenly distributed
over the lung volume, occupying 10% of
the total lung volume.
10
1 cm0% 12% centred 5 Lesions with a diameter of 1 cm with 0%
activity concentration, centred to the large
bronchial tubes, occupying 12% of the total
lung volume.
12
2 cm50% 10% evenly 6 Lesions with a diameter of 2 cm with 50%
activity concentration, evenly distributed
over the lung volume, occupying 10% of
the total lung volume.
5
2 cm0% 10% evenly 7 Lesions with a diameter of 2 cm with 0%
activity concentration, evenly distributed
over the lung volume, occupying 10% of
the total lung volume.
10
2 cm50% 48% evenly 8 Lesions with a diameter of 2 cm with 50%
activity concentration, evenly distributed
over the lung volume, occupying 48% of
the total lung volume.
24
2 cm25% 48% evenly 9 Lesions with a diameter of 2 cm with 25%
activity concentration, evenly distributed
over the lung volume, occupying 48% of
the total lung volume.
36
Coronal slices of the phantom include simulated motion artefacts.
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blurring. The isotope 99mTc was used and the energy win-
dow was set between 130 and 154 keV. The gamma camera
rotation orbit was non-circular, corresponding to the auto-
contouring system used in our clinic. The centre of rotation
to collimator distance varied between 17 and 25 cm.
Simulations were made for a GE Infinia gamma camera
(9.5-mm thick NaI detector) equipped with a low-energy
high-resolution collimator (LEHR). Projections were col-
lected at 128 different angles, equally spaced, over 360°, in
128×128 matrices (3.30 × 3.30 mm2 per detector element).
A total of 1.8 × 1010 photons were simulated with the
homogeneous activity concentration (the simulated normal)
resulting in projections with very low noise levels. The coef-
ficient of variance CV (see Equation 1 in Additional file 1)
of one pixel element within the high-count area of the lung
in one single projection determined from three consecutive
simulations was 0.5%.
Normalisation and statistical noise
The aim of generating low-noise projections was to be
able to adjust the mean number of total counts to that
representative of a clinical study, and to generate
Poisson noise [23,24] typical of realistic projections. The
mean number of counts in the simulated projections
was set to 3.635 × 106. This value was based on a virtual
administered activity of 125 MBq for each activity distri-
bution, an acquisition time of 10 s per projection and
the average sensitivity (cps MBq−1) of 20 planar lung
perfusion studies at Linkoping University Hospital
performed in 2009. The acquisition parameters used
then were the following: 99mTc macro-aggregated albu-
min, LEHR collimator and an energy window of 130-154
keV. Before reconstruction, the mean number of counts
in individual pixel elements in the projections was re-
placed by random deviates drawn from a Poisson
distribution.Table 2 Subjects’ gender, age, FEV1, FEV1/VC and AUC(CVT)
Subject Label Gender Age (years)










FEV1, forced expiratory volume in one second (% predicted; predicted normal value
for ages <65 years and <0.65 for ages ≥65 years according to the Swedish guidelin
details see ‘Methods’).For each activity distribution, 20 noise realisations
were created, imitating 20 SPECT acquisitions of the
same activity distribution. The CV value of one pixel
element within the high-count area of the lung in one
projection, based on the 20 noise realisations of the sim-
ulated normal, was about 15%.
Human subjects and their data acquisition
The patient group consisted of five grade 3 (FEV1/VC <
0.70, 30% ≤ FEV1 < 50% of predicted) and 4 (FEV1/VC <
0.70, FEV1 < 30% of predicted) [25-27] COPD patients
(P1 to P5), registered at the department of Pulmonary
Medicine, Linkoping University Hospital, all with ad-
vanced emphysema demonstrated on HRCT. Mean
values ± 1 SD (expressed as percentage of predicted
values) for vital capacity (VC), residual volume (RV),
total lung capacity (TLC) and the diffusion capacity of
the lung for carbon monoxide (DLCO) for the patient
group were 84 ± 8, 211 ± 39, 127 ± 9 and 38 ± 7, re-
spectively. The group of healthy volunteers consisted of
five (H1 to H5) life-long non-smokers (>40 years old,
FEV1 >80% predicted), without history of allergy. Ob-
struction was defined as FEV1/VC < 0.7 for ages <65
years and <0.65 for ages ≥65 years according to the
Swedish guidelines for COPD [28]. Corresponding mean
values ± 1 SD for the volunteer group were 104 ± 11,
126 ± 10, 110 ± 8 and 99 ± 16, respectively. All human
subjects were included after informed and written
consent were obtained. Additional characteristics of the
subjects are presented in Table 2. The regional Ethics
Review Board at the University of Linkoping approved
the study protocol.
Technetium (99mTc) was generated (Covidien, Dublin,
Ireland) and thereafter Technegas was prepared and
delivered from the Technegas generator according to the
manufacturer’s instructions. Starting from functional











s according to Hedenstrom [26,27]), obstruction was defined as FEV1/VC < 0.7
es for COPD [28], AUC(CVTc, area under the curve defined by the CVT value (for
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expired. This manoeuvre was repeated until approxi-
mately 75 MBq 99mTc (according to the gamma camera)
had been deposited in the lungs. The subjects inhaled
the gas in a supine position immediately before the ven-
tilation SPECT acquisition in the same position. The
data was acquired using a double-headed gamma camera
(GE Infinia, Milwaukee, WI, USA) with a LEHR collima-
tor. There were 120 projections (20 s each) equally
spaced over 360°, and each projection was a 128 × 128
element matrix with a pixel size of 3.45 × 3.45 mm2.
Auto-contouring and a 130 to 154 keV energy window
were employed. The CV value of the two regions of
interest (3 × 3 pixels) within the high-count area of the
lung in two projections, based on the five healthy volun-
teers, was about 17%, consistent with the result of the
simulated normal.
After the SPECT acquisition, without moving the pa-
tient, a low-dose CT examination was performed using
the X-ray equipment mounted on the gamma camera
(Hawkeye, GE Infinia, Milwaukee, WI, USA).
The effective dose for this protocol is estimated to be
3.1 mSv (1.1 mSv for SPECT [29] and 2 mSv for CT),
which required a total acquisition time of 25 min.
SPECT reconstruction and filtering
Each set of 20 noisy projections in the simulated COPD
study and subject projections in the human study was
reconstructed using the iterative ordered subset expec-
tation maximisation reconstruction software developed
at Johns Hopkins University, Baltimore, MD, USA.
The reconstruction included correction for attenuation,
scatter and collimator detector response (CDR). In the
simulated COPD study, the phantom attenuation was
corrected for using an attenuation map of the phantom,
and in the human study the CT scans were used for
attenuation correction. Scatter correction was performed
using the effective source scatter estimation (ESSE)
[23,30]. The ESSE model requires scatter kernel files,AUC(CVT)=52%
CVT=20.5%
a)
Figure 2 Illustration of the area under the curve for CV-values greate
noise realisations of the CV values corresponding to (a) distribution 1, the s
set to 20.5% for the simulated distributions. Indicated in the figure are thewhich were generated using Monte Carlo simulations
with SIMIND. An analytic geometrical model for CDR
compensation was used. Reconstructions were performed
using ten iterations and 16 subsets. The side length of a
voxel in a reconstructed image was for the simulated
COPD study and human study with 3.30 mm and 3.45
mm respectively. The reconstructed images were post-
filtered with a Butterworth filter [31] with a cut-off fre-
quency of 0.5 cm−1 and a power of 6 (i.e. order 3).
Method for analysis of inhomogeneities
The 3D reconstruction was subjected to a 3 × 3 × 3 cm3
(i.e. 9 × 9 × 9 voxels) cubic kernel that stepped through
the volume. A step was a one-voxel-step in the x, y or z
direction. In each step, CV was calculated. An additional
file shows the behaviour of the CV value (see Additional
file 1). The kernel defined which voxels of the reconstruc-
tion the CV calculations were based on. Voxels outside
the defined lung volume were excluded from the CV ana-
lysis. The CV values were stored in the middle position of
the kernel in a new matrix, the CV matrix, with the same
matrix size as the reconstruction. The CV values for each
reconstruction were also plotted as a frequency function
with an area under the curve (AUC) of 100% (see Figure 2).
The relative numbers of CV values in bins of width of 1%
were used to construct the frequency functions.
Defining the extension of the lung
For the simulated COPD study, the lung voxels in distri-
bution 1 (Table 1), containing values greater than half
the maximum lung value, were set to be the lung.
For the human study, semi-automated lung segmenta-
tion was used on each subject based on the individual CT
acquisition and an empirical linear attenuation coefficient
threshold value of 0.12 cm−1. The linear attenuation co-
efficients for lung tissue and soft tissue are approximately
0.04 and 0.16 cm−1, respectively (ICRU 44). Therefore, the
defined lung for each subject in the human study will in-
clude the whole lung cavity.b) AUC(CVT)=89%
r than the threshold value CVT. The mean frequency functions of 20
imulated normal, and (b) distribution 8, ‘2-cm50% 48% evenly.’ CVT was
calculated AUC(CVT) values for the two distributions.
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Due to the limited spatial resolution of the SPECT system,
with a full width at half maximum (FWHM) of about 1 to
1.5 cm, the reconstructed activity distribution around the
edge of the lung will be blurred. Voxels involved in the
lung edge will result in high CV values, which are not ne-
cessarily correlated to inhomogeneity of the lung activity
distribution. Therefore, a one-voxel-wide layer of the lung
was ‘peeled off ’ from the periphery of the segmented lung,
thereby creating a reduced lung volume with most of this
edge effect excluded.
Threshold values and area under curve
The area under the frequency function (AUC) for CV
values greater than a threshold value for CV, called CVT,
was defined as AUC(CVT) and expressed as the percent-
age of the total AUC (Figure 2). Since the future aim is
to discriminate between healthy distributions and less
severe COPD distributions, the optimal CVT value was
evaluated by finding the largest separation between cor-
responding AUC(CVT) values for the healthy ‘uniform’
and the ‘1-cm50% 10% evenly’ distributions (distributions
1 and 2 in Table 1) in the simulated COPD study. CVT
values ranging from 1% to 25% were evaluated. The
largest separation was found for the CV value corre-
sponding to the peak value of the mean frequency func-
tion of the healthy distributions, i.e. the modal value,
plus about 1%. The modal value was used for simplicity.
In the simulated COPD study, the healthy mean fre-
quency function is based on the 20 noise realisations of
the uniform activity distribution; and in the human
study, it is based on the activity distributions of the five
healthy volunteers. AUC(CVT) was then calculated for
all activity distributions in both the simulated COPD
study and the human study.
In the simulated COPD study, the group of 20 AUC
(CVT) values, based on the 20 noise realisations of theFigure 3 The mean AUC(CVT) value for each activity distribution as lis
light grey bars show simulated COPD. Bars with dashed outline correspond
distribution is written in the bars. The error bars show a 95% CI, based on tsimulated normal distribution, was compared with the cor-
responding groups of simulated COPD distributions, using
the non-parametric Mann–Whitney U test and Statistica
(version 9, StatSoft, Tulsa, Oklahoma, USA). This test was
used because no assumption of normal distributions was
made. The same test was performed comparing the five
COPD patients with the five healthy volunteers.
Image and computer processing
The addition of Poisson noise, post-filtration and evalu-
ation were performed using in-house software developed
in Interactive Data Language (IDL; ITT Visual Informa-
tion Solutions, Boulder, CO, USA).
Results and discussion
Results of the Monte Carlo-simulated COPD study
The AUC(CVT) was calculated for all simulated activity
distributions using a CVT = 20.5%, as illustrated in
Figure 2. Figure 3 shows that the AUC(CVT) values
for all simulated COPD distributions tested [reflecting
COPD changes of different severity (distributions 2 to
9)] can be separated statistically from the corresponding
value of the simulated normal distribution of the healthy
lung (distribution 1). The mean AUC(CVT) value for the
simulated normal distribution is 52% ± 1% (95% confi-
dence interval (CI)). For simulated COPD distributions
with lesions with a diameter of 1 cm, corresponding
values range from 58% to 65%, and for lesions with a
diameter of 2 cm, from 82% to 100%. Comparing AUC
(CVT) values for distributions with the same lesion size
and localisation but different activity levels (i.e. compar-
ing the distributions 2 with 4, 3 with 5, 6 with 7 and 8
with 9) shows that the one with the lowest activity level
in the lesions has the highest AUC(CVT) value with one
exception. For distributions 3 and 5, no difference in
AUC(CVT) values are found. There is a statistically
significant difference (n1 = n2 = 20, p < < 0.001, two-ted in Table 1. The dark grey bars show simulated normal, and the
to clustered distributions. The total reduction of ventilation for each
he 20 noise realisations.
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realisations of distribution 1 (the simulated normal) and
distribution 2 (1 cm50% 10% evenly). Comparing AUC
(CVT) values for distributions with the same lesion size
and activity levels but different localisation shows a
difference between distributions 2 and 3 (with a total
reduction of ventilation of 5% and 6% respectively, p <
0.002), but not between 4 and 5 (with a total reduction
of ventilation of 10% and 12% respectively).
Figure 4 shows that the differences shown in
Figure 3 are due to shifts of the frequency functions,
i.e. the proportion of high CV values is higher for the
simulated COPD distributions compared to the simu-
lated normal. The frequency function of the clustered
distribution 5 (1 cm0% 12% centred) has a larger pro-
portion of high CV values compared to the ‘evenly’
distributions (see Figure 4). For the clustered distribu-
tion 3 (1 cm50% 12% centred) this tale towards high
CV values is less pronounced, and its frequency func-
tion is in between distribution 4 (1 cm0% 10% evenly)
and 5.
Figures 3 and 4 show that with the presented
method we can identify a ventilation reduction not
visible to the human eye in the reconstructed images,
as shown in Figure 5 (row 2, column B). The CV
values corresponding to evenly distributed 1 cm le-
sions are relatively constant (rows 2 and 3, column
C) compared to the CV values corresponding to
evenly distributed 2 cm lesions (distribution 7 row 5,
column C) where the surfaces of the lesions are vis-
ible. The CV matrix for the clustered distribution
clearly shows the surface of the cluster (distribution 5Figure 4 Frequency functions of the CV- values for simulated
distributions. The mean frequency functions of 20 noise realisations
of the CV values corresponding to distribution 1, the simulated
normal (solid line); distribution 4, ‘1 cm0% 10% evenly’ (dash-dotted);
distribution 5, ‘1 cm0% 12% centred’ (dash-dot-dot-dotted); and
distribution 8, ‘2 cm50% 48% evenly’ (dashed).Only four curves out of
nine are shown for clarity.row 4, column C). Due to the limited number of
counts in the acquired projections there are fluctua-
tions inside the lung even for the simulated normal.
Notably, respiratory motions give rise to higher CV
values at the base of the lung compared to the apex
(column C), and, consequently, are not a result of re-
duced ventilation.Results of the human study
Figure 6 shows that the mean AUC(CVT) value for the
healthy volunteers was 65% ± 13% (95% CI), while the
mean AUC(CVT) value for the patients was 100% ± 1%
(95% CI). There was a statistical significant difference
(n1 = n2 = 5, p <0.05, two-tailed) between the AUC
(CVT) values for the volunteers and the patients.
The in vivo study also shows the expected substantial
difference between the healthy volunteers and the pa-
tient group when all CV frequency functions are
summarised, Figure 7a. The curves of the healthy volun-
teers are gathered to the left on the abscissa and are
more peaked in shape compared to the corresponding
curves of the patients, which are shifted more to the
right on the abscissa and are wider in shape. In Figure 7b,
the mean CV curve of all five healthy volunteers is
shown, from which a CV threshold value, CVT = 22%, is
obtained. The calculated AUC(CVT) values of all human
subjects are summarised in Table 2.
Figure 8 shows reconstructed images and CV matrices
for healthy volunteer H3 and patient P3. Notably,
while the healthy volunteers all demonstrate high CV
values in the lung bases due to respiratory motions,
this was not observed in patients (column C), prob-
ably because of restricted movement of the diaphragm.
Patients with advanced emphysema are expected to
demonstrate hot spots in their ventilation distribu-
tions. Cubic-shaped areas with the size of the cubic
kernel could be seen around the hot spots, and these
contributed to the wide distribution of the frequency
functions of the patients (see Figure 7a). However, also
in volumes without hot spots, higher CV values were
found in the patients than in the healthy volunteers.Discussion
In the present study, we have modified a method by Xu
et al. in order to improve the quantification of ventila-
tion inhomogeneities in a phantom model of a COPD
lung. In contrast to what has been previously reported,
our improved method was able to assess even minor
COPD changes by using the AUC(CVT) value, as a
global value of ventilation inhomogeneities, and to
discriminate these changes from a model of a healthy
homogeneous lung. The present pilot study also shows
that our way of performing lung SPECT and calculating
Figure 6 The mean AUC(CVT) for the human in vivo study with
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Figure 5 Reconstructed images and CV matrices for simulated distributions. Each row shows coronal slices based on the activity
distributions 1, 2, 4, 5 and 7 in Table 1, (A); the activity distribution, (B); a filtered reconstruction and, (C); corresponding CV matrix.
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healthy volunteers from patients with advanced COPD.
The NCAT software is able to create thorax voxel
phantoms of a human, based on a fine-segmented male
[32]. The NCAT software is flexible since different sizes
and shapes of different tissues can be selected and
natural movements caused by heartbeat and respiration
can be modelled. Because most of the COPD patients
are elderly [33], we decided to use a lung volume corre-
sponding to a 65-year-old male. Low-ventilated regions,
associated with anatomical changes of COPD, are dis-
tributed in patients in various ways, and these volumes
can vary between 0.5 mm (the size of a few alveoli) and
several centimetres in diameter. One of the aims of the
present study was to mimic mild to moderate changes of
COPD, and therefore small lesions were of interest.
Since the spatial resolution of the SPECT system is
about 1 to 1.5 cm (expressed in FWHM), the lesions
Figure 7 Frequency functions of the CV values for the human study. (a) The frequency functions of the CV values corresponding to healthy
subject H1 (solid line), H2 (dotted), H3 (dashed), H4 (dash-dotted), H5 (dash-dot-dotted), and patients with bold line styles; P1 (solid line); P2
(dotted); P3 (dashed); P4 (dash-dotted); P5 (dash-dot-dotted). (b) An expanded view of the frequency functions for the healthy subjects and their
mean frequency function (bold line with open circles). The arrow shows the CV threshold value for the human study at 22%.
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ous studies on the distribution of ventilation inhomoge-
neities in mild COPD, we assumed that COPD lesions
are either evenly distributed in the whole lung volume
or centred in clusters (see Table 1). In this way, our
method was evaluated on two groups with completely
different lesion distributions. The density of the lesions
was approximated to be the same as for the healthy lung
tissue since we aimed to model less severe changes of
COPD. Indeed, activity distribution 1 cm50% 10% (distri-
bution 2 in Table 1) illustrates activity inhomogeneities
that are almost too small for the SPECT system to re-
solve, and, clearly, not visible to the human eye in the
reconstructed image (cf. Figure 5). Thus, we believe this
distribution would be a good representative of a case of
mild COPD. However, it should be pointed out that the
activity distributions selected in the different cases were
not primarily chosen because of their consistency withA B
H3
P3
Figure 8 Reconstructed images and CV matrices for healthy voluntee
for patient P3, showing (A); coronal slices of the attenuation map, (B); a filtbiology, but more because of our ability to unambigu-
ously describe them.
How does the magnitude of the present volume of ven-
tilation defects compare to reductions of spirometric vari-
ables? Fifty percent reduction of the ventilation in 10%
of the lung volume (distributions 2 and 6 in Table 1)
corresponds to the 5% total reduction of the functioning
lung tissue. Although not exactly comparable, reductions
of spirometric variables of similar magnitudes are likely
to remain undetected, as the normal range of spiromet-
ric variables is roughly ±15% to 20%. Thus, in our an-
thropomorphic phantom, we consider most of the present
volume of ventilation defects as comparatively small.
When considering the result of the presented quantita-
tive method, a number of important parameters have to
be accounted for, e.g. count density (statistical noise),
collimator, number of iterations and subsets, reconstruc-
tion compensations and post-filtering. In this work we C 
0%                     180%
r H3 and patient P3. One row for healthy volunteer H3 and one row
ered reconstruction and, (C); corresponding CV matrix.
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important factors are the method-specific ones, i.e. the
lung edge effects and kernel size that we evaluated. The
resolution of the SPECT system is limited, and therefore,
high CV values will always be found in the periphery of
the healthy lung. Lung edges with low activity lesions will
instead give lower CV values. High CV values due to
healthy edges reduce the differences between frequency
functions from healthy and unhealthy activity distribu-
tions; i.e. they also reduce the separation between corre-
sponding AUC(CVT) values. Therefore, the CV analysis
was performed in a volume that had part of the edge effect
excluded. Exclusion of a one-voxel layer, however, removes
21% of the phantom lung and 20% to 29% of the human
lung parenchyma from the analysis, which is why small
lesions in the periphery might not be detected. The kernel
approach used does not exclude any additional volume of
the lung in the analysis. Kernels with five different side
lengths were evaluated in the simulated COPD study, i.e.
1.0, 1.7, 2.3, 3.0, 3.6 and 4.3 cm. Increasing the side length
resulted in an increasing differentiation between the AUC
(CVT) values of the simulated normal and 1 cm
50% 10%
evenly distribution (distributions 1 and 2 in Table 1).
However, for the two largest cube sizes tested, in combin-
ation with some values of the above-mentioned parame-
ters (e.g. LEHR collimator, a Butterworth post-filter with a
cut-off frequency of 0.3 cm−1 and a power of 6, 125 MBq,
ten iterations and 16 subsets and no exclusion of edge
voxels), the CV frequency functions of the simulated nor-
mal distribution were double peaked. Therefore, to minim-
ise the risk of double peaks in a clinical setting, we chose a
kernel with the side length of 3 cm, including 729 voxels.
The present method of quantitative analysis has two
major advantages. Firstly, it discriminates cases with the
same loss of ventilation, but with inhomogeneities differ-
ently distributed and with different lesion sizes, from the
simulated normal lung, even when COPD changes are
minor. For example, distributions 2 (1 cm50% 10% evenly),
3 (1 cm50% 12% centred) and 6 (2 cm50% 10% evenly) in
Figure 3 all represent only a 5% to 6% total reduction of
ventilation, but their resulting AUC(CVT) values are well
above the value of the normal lung. The same holds true
for distributions 4 (1 cm0% 10% evenly), 5 (1 cm0% 12%
centred) and 7 (2 cm0% 10% evenly), which all correspond
to a 10% to 12% total reduction of ventilation. Secondly,
for the same lesion size, increasing AUC(CVT) values tend
to correlate with decreasing total ventilation. For example,
distribution 6 (2 cm50% 10% evenly) in Figure 3, corre-
sponding to a 5% total reduction of ventilation, gives a
lower AUC(CVT) value than distribution 7 (2 cm
0% 10%
evenly) corresponding to a 10% total reduction of ventila-
tion. But clearly, even with the same loss of ventilation,
activity distributions with a few large lesions (≥1.5 cm) with
low activity will give higher AUC(CVT) values than activitydistributions with many small lesions (≤1.5 cm) with rela-
tively high activity in each lesion (e.g. see Figure 3 and
Figure 5, distributions 4 and 7 at rows 3 and 5, column C).
It is desirable that distributions with the same total
reduction of ventilation result in the same level of AUC
(CVT) values independent of lesion shape and distribu-
tion. This is the case of the evenly distribution 4 and the
clustered distribution 5 (with a total reduction of venti-
lation of 10% to 12%). However, the difference in distri-
bution can be seen in the frequency functions (Figure 4)
and in corresponding CV matrices (Figure 5). Clusters
positioned in other parts of the lung have not been in-
vestigated. Factors influencing the result are the volume
and activity concentration of the spheres in the cluster
and the size of the cluster’s surface area towards the uni-
form part of the lung, and not where in the lung the
cluster is positioned.
One limitation of the present method is its loss of
sensitivity when COPD changes become more advanced.
An activity distribution with an AUC(CVT) value close
to 100% can easily be separated from the simulated
normal distribution; however, further reduction of venti-
lation will only result in an almost unchanged AUC
(CVT) value (because 100% is the highest possible value).
On the other hand, the present method is customised to
detect early and minor COPD changes and not to be a
diagnostic for advanced emphysema, for which methods
such as HRCT are more useful. Furthermore, in cases of
advanced COPD, the appearance of the frequency func-
tion of CV values can be used directly, without calcula-
ting the CVT and the AUC(CVT), to estimate the COPD
severity.
The activity distribution in healthy humans is not as
homogeneous as the simulated normal distribution used
in the simulated COPD study, which might be due to
the shape of the bronchial tree and the gravity influen-
cing the lung. This difference is seen in the defined CVT
values, 20.5% for the simulated COPD study and 22.0%
for the human study. Furthermore, the human thorax
exhibits a large variety of sizes and shapes. In order to
decrease the influence of the lung size, AUC(CVT)
values are presented in a percentage of total lung volume
instead of absolute values. This prevents large healthy
lungs giving high AUC(CVT) values and small inhomo-
geneous lungs giving low AUC(CVT) values. However, a
larger 95% CI of the AUC(CVT) value of the healthy
volunteers of ±13% around the mean compared to the
simulated COPD study of ±1% was found. This large vari-
ation of the healthy volunteers might be due to genetic
variations, age effects, different histories of occupational
and environmental exposures of noxious particles and
gases e.g. passive exposure to tobacco smoke and varying
techniques of inhaling the Technegas. The total amount
of inhaled Technegas, expressed in megabecquerel, also
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tion distribution based on a low activity level will contain
higher statistical noise compared to a distribution based
on a higher activity level. Higher noise levels will result in
higher CV values. A variation in the amount of inhaled
Technegas was observed between the human subjects.
Therefore, due to different activity levels, small shifts
along the CV axis of the frequency functions in
Figure 7 are present. Procedures resulting in more repro-
ducible amounts of inhaled Technegas and normalisation
methods that after image acquisition can compensate for
such shifts will be further investigated. Reproducibility
may be improved also by control of the depth and inhal-
ation flow rate of the Technegas administration. In par-
ticular, the inhalation flow rate influences the ventilation
distribution in normal subjects [34] and almost certainly
also the deposition in patients with COPD.
The activity distribution in the COPD patients was
characterised by areas of low activity and areas of high
activity i.e. hot spots. Low activity areas are caused by
reduced regional ventilation resulting in low Technegas
particle deposition. Reduced regional ventilation may be
caused by local obstruction of peripheral airways and/or
by emphysematous areas with low elasticity. Hot spots
on the other hand, as pointed out by Pellegrino et al.
[35], may be caused by obstruction of central airways
probably resulting in some Technegas impaction during
inspiration but in particular by facilitating regional air-
flow limitation during expiration. Airflow limitation im-
plies pronounced and oscillating narrowing of airway
walls causing strong turbulence resulting in high impac-
tion of Technegas particles during expiration [35]. These
hot spots were included in the assessment of the CV
values. This might be considered as a weakness of the
present method, since the intention behind the use of
CV values was to identify low activity volumes as an in-
dication of disease and not to generate high CV values
due to abnormal uptake. On the other hand, such hot
spots are typical of the COPD lung and might therefore
be accepted as contributing to the analysis. How these
hot spots influence the analysis will be evaluated in our
future work. Presently, we investigate if the present
method is reliable enough for detection of COPD changes
in smokers without manifested COPD.
Conclusion
The proposed method generates as a global measure of
ventilation inhomogeneities, an AUC (CVT) value that
can differentiate with statistical significance between the
activity distributions corresponding to varying severity of
COPD changes and the healthy normal activity distribu-
tion in a breathing lung phantom. The method can also
clearly differentiate between five patients with COPD of
grades 3 and 4, and five healthy non-smokers. Therefore,the AUC (CVT) method is promising for assessment of
COPD inhomogeneities in the lung SPECT ventilation
image. The potential of the AUC(CVT) method to de-
tect less advanced COPD in patients, e.g. smokers with-
out manifested COPD, needs further investigations.
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Additional file 1: Figure S1. A slice through a 3D geometry with a
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right, and d) to the small 5-level sphere at the far right.
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